Forward-thinking stevia standards snag company award

IRVINE, Calif., Jan. 26 /PRNewswire-FirstCall/ — ChromaDex Corporation, (OTC Bulletin Board: CDXC) a leader in phytochemical reference standards and contract research, announced today that Nutrition Business Journal, a leading nutrition, natural products and alternative health care magazine, selected the Company as one of the 2008 NBJ Scientific Achievement Award recipients for its achievement in setting stevia standards as part of its work with Cargill.

“The broad commercial application of stevia has long been anticipated, and our work with Cargill has set the standard for safety and quality,” said Frank Jaksch, CEO and co-founder of ChromaDex. “We have worked hard to be the leader in reference standards and we appreciate the validation of our work by Nutrition Business Journal.”

As part of its partnership with Cargill, Chromadex will supply global analytical reference standards and research materials for the individual sweet components of stevia, a natural product originating from the leaves of the stevia plant. With no previously accepted standards, this is the first time food and beverage companies can validate quality of stevia for use in consumer products.

NBJ Business Achievement Awards are awarded annually to companies that have demonstrated achievement in categories such as Management Achievement, Investment in the Future, Education, Environment & Sustainability, Organic Excellence and Wall Street Award for Stock Performance. Award winners will be honored at a dinner in July at the NBJ Summit, to be held at the St. Regis Monarch Beach Resort in Dana Point, California.

About ChromaDex

ChromaDex is a leader in the development of Phytochemical and Botanical Reference Standards and the creation of associated intellectual property. ChromaDex is committed to sustainable “Green chemistry” and provides the dietary supplement, food, beverage, nutraceutical and cosmetic industries with the analytical tools and services to meet product regulatory, quality, efficacy and safety standards.

 

Comments

comments